Houston-based Social Mama uses its platform to connect mothers based on location, interests, and the things their children have in common. Courtesy of Social Mama

Sometimes, to be a mom, is to feel utterly alone. Not every mom is the same, and it's tough for women to find the right support systems — people who are going through or have gone through the same struggles.

A new Houston-based app, Social Mama, is providing a solution. The technology uses artificial intelligence and data collection to learn about its users and match them to other users based on their location and specifications. It's like online dating, but for mothers, co-founder Amanda Ducach says.

"The social impact of the product is so important," Ducach says. "I can't explain to you the isolation and the problem that exists in motherhood. I was completely unaware of it before I started the company."

The idea came to Ducach when she moved across the country to Houston from Minneapolis. Her best friend was in sudden need of a new network — preferably moms who liked wine, spoke Spanish, and had peanut-free households so her son could play without the risk of his allergies. Wanting to help the friend they had abandoned, Ducach and her husband, who is a data architect, decided to try to find a way to get there friend a new friend she could relate to.

"We realized there was nothing that existed that allowed two mothers to connect based on where they lived and their interests, that also took information about their children in account," Ducach says. "We decided to create it."

The app, which is based out of Station Houston, has been in beta with a couple thousand users, but, based on users' experiences, Ducach says they are making a lot of changes before they launch to the public in spring of this year.

Beta lessons learned
Thinking that mothers are too busy for lengthy setups, Ducach made signing up for Social Mama simple.

"We completely put out the wrong product, which isn't a bad thing," Ducach says. "We assumed they would want us to figure out who to match them with, but it's the complete opposite."

The mothers are happy to spend 10 to 15 minutes during the sign in process after downloading the free app, Ducach says, because they want to give the app as much information as possible. They are looking for niche matches.

Another surprise for Ducach was that, similar to dating apps, starting a conversation with a stranger — ideally matched or otherwise — is tough.

"We thought that because it was two women, and there's no sexual chemistry, that it would be easy for them to reach out and start a conversation," Ducach says. "But they actually still find it incredibly awkward."

The app will have things like ice breakers or games to help get the ball rolling.

She also didn't think the mothers would want something like a newsfeed. However, users who might not be in a highly populated city primed for face-to-face friendship still might want access to asking fellow mothers advice in a post on a forum. So, Social Mama will have a customizable, AI-generated newsfeed — kind of like a forum. Posts will have tags, and users will only see things they have an interest in.

"As you continue to use the app, it will create a persona for you," Ducach says, "and it's not mothers that are like you, but mothers you tell us you're looking for."

The app will know when a mother transitions from newborn mother to toddler mother, so that her matches stay relevant as her child ages.

Making an impact
This year, Social Mama will go live in the spring, and Ducach has several growth plans surrounding launch. The app will be fundraising for pre-seed money in 2019, and expanding the team to include a data scientist, as well as other department hires. The company currently has eight employees — most of which are in the Houston HQ — but some reside in Boston and around the world.

The core components of the app are the matching and AI-generated newsfeed, but hosting event meet ups is another successful avenue for the app, as is the potential to recommend products to the mothers. Ducach says this could be a part of the the app's business plan, as is a subscription model for moms to opt into extra perks.

"We know so much information about these moms that they are telling us, that we have the ability to send them recommended products from other mothers," she says.

While Ducach says the initial launch will only be in Houston, the app is already in big demand worldwide. She says they had to shut down the beta version because they had so many international downloads and they were concerned about cybersecurity.

"Moms want this in Germany, China, and Cypress, Texas," Ducach says. "It's really a need everywhere, and we're really excited to expand and see which markets take off."

Ducach says she is excited for the app to go live and affect these moms' lives.

"We're really excited because it should really change the trajectory of these women's lives and create a support group they've never had before," Ducach says.

social mamaSocial Mama went through a beta phase, but when it launches in the spring, it will be totally different. Courtesy of Social Mama

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”